And at these points, they should know the role Crohn’s and colitis can play, if at all. On CCFA’s June 16th webcast/teleconference,
New York, NY (Vocus) May 22, 2010
Approximately half of the 1.4 million Americans living with the chronic and often debilitating inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis, are female. On Wednesday, June 16th, at 8 PM ET, female Crohn's and colitis patients and their loved ones can tune into a Crohn's & Colitis Foundation of America (CCFA) interactive educational webcast/teleconference entitled, "IBD & She: Focusing on Living While Managing IBD." The event will be hosted by national experts and researchers Sunanda Kane, MD, MSPH, Associate Professor of Medicine, Mayo Clinic College of Medicine, and Uma Mahadevan-Velayos, MD, Associate Professor of Clinical Medicine and Associate Director of Clinical Research Center for Colitis and Crohn's Disease, University of California San Francisco. Drs. Kane and Mahadevan offer guidance to help women with Crohn’s disease and ulcerative colitis better manage these diseases, and answer audience questions during an interactive question and answer session.
Topics that will be covered include:
- Fertility & Pregnancy, including getting pregnant, being pregnant, medications and pregnancy, and delivery
- Menstruation and Menopause
- Hormones and Hysterectomy
- Medication interactions with other drugs including birth control
- Breast Feeding
“Women living with Crohn’s disease and ulcerative colitis often come to a point in their lives when they are experiencing situations unique to female patients—whether it be trying to become pregnant, taking birth control, or going through menopause,” says Drs. Kane and Mahadevan. “And at these points, they should know the role Crohn’s and colitis can play, if at all. On CCFA’s June 16th webcast/teleconference, “IBD & She: Focusing on Living While Managing IBD” we will provide guidance to managing these diseases.”
Board certified in internal medicine and gastroenterology, Dr. Kane specializes in women's issues in IBD including pregnancy and infertility and medication compliance issues. She serves as Chair of CCFA’s Patient Education Committee, and is a Member of the Board of Trustees of the American College of Gastroenterology. Dr. Kane received her medical degree from Rush Medical College of the University of Chicago.
An expert in inflammatory bowel disease, particularly as it related to pregnancy and fertility, new drug trials and pouchitis, Dr. Mahadevan takes interest in developing novel therapies for the condition, as well as investigating pregnancy and fertility outcomes in IBD. Lead investigator on the CCFA-funded Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes study, Dr. Mahadevan, Past Chair of CCFA’s Patient Education Committee, is board certified in internal medicine and gastroenterology and received her medical degree from the State University of New York, Brooklyn College of Medicine.
Registration is available at no cost to participants via an online portal at http://www.ccfa.org/webcasts/womenandibd and by phone at 1-877-547-5641 ext. 312. The Crohn’s & Colitis Foundation offers webcasts/teleconferences on an ongoing basis for the IBD community, typically drawing 1,500 to 2,000 patients nationwide. Archived webcasts/teleconferences can be accessed at http://www.ccfa.org/webcasts/womenandibd.
About Crohn's Disease & Ulcerative Colitis
Crohn's disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn's disease may attack anywhere from the mouth to the anus, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn's disease or ulcerative colitis, with as many as 150,000 under the age of 18. Most people develop the diseases between the ages of 15 and 35.
About the Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 79 cents of every dollar the Foundation spends goes to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance (give.org) and the American Institute of Philanthropy (charitywatch.org). For more information, contact the Foundation at 800-932-2423 or visit http://www.ccfa.org. Join CCFA on Facebook at http://apps.facebook.com/supportccfa/ and follow CCFA on Twitter at http://www.twitter.com/ccfa.